Short-term tools to measure responsiveness to growth hormone replacement

Area of Science:

• Endocrinology
• Pediatric Endocrinology
• Adult Endocrinology

Background:

• Growth hormone (GH) replacement therapy is a long-term, costly treatment requiring daily injections.
• Developing short-term tests to predict treatment response is a significant clinical need.
• The insulin-like growth factor I (IGF-I) generation test was initially proposed for selecting GH responders in children.

Purpose of the Study:

• To evaluate the reliability of short-term tests in predicting long-term clinical response to GH replacement.
• To assess the correlation between short-term serum IGF-I increase and linear growth in children.
• To determine the availability of outcome measures and IGF-I correlation for GH-deficient adults.

Main Methods:

• Review of studies investigating short-term tests for GH replacement response.
• Analysis of the correlation between serum IGF-I levels and clinical outcomes (linear growth, body composition, physical fitness).
• Evaluation of existing outcome measures for GH-deficient adults.

Main Results:

• A positive correlation between short-term IGF-I increase and linear growth was reported in only a minority of studies.
• No single outcome measure is established for GH-deficient adults.
• No evidence links IGF-I levels to improvements in body composition or physical fitness in adults.

Conclusions:

• Currently, no dependable short-term test exists to predict long-term response to GH replacement in either children or adults.
• Serum IGF-I measurement is essential for monitoring GH replacement therapy in GH-deficient patients for safety.
• Further research is needed to develop reliable predictive markers for GH therapy efficacy.